The bioavailability of cytarabine in dogs with meningoencephalitis of unknown etiology through iontophoresis and rectal delivery

BACKGROUND: Cytarabine (CA) is used to treat dogs with meningoencephalitis of unknown etiology (MUE) by subcutaneous or intravenous administration. AIM: The objective was to investigate transdermal iontophoresis and rectal administration as alternative routes of CA delivery. METHODS: Two client-owne...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancini, Shelby L., Early, Peter J., Pastina, Bethany O., Olby, Natasha J., Mariani, Christopher L., Munana, Karen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty of Veterinary Medicine 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057209/
https://www.ncbi.nlm.nih.gov/pubmed/33898281
http://dx.doi.org/10.4314/ovj.v11i1.6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057209/
https://www.ncbi.nlm.nih.gov/pubmed/33898281
http://dx.doi.org/10.4314/ovj.v11i1.6

Ejemplares similares